menu
    • menu

    Company profile for Kangpu Biopharmaceuticals

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Kangpu Biopharmaceuticals Launched Phase I Study of Novel Cancer Therapy Candidate KPG-121 in Patients with Metastatic Castration-Resistant Prostate Cancer in Collaboration with Accelovance, Inc.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Kangpu BiopharmaceuticalsGreece Flag
    Country
    Country
    Greece
    Address
    Address
    7 Stratigi Street Neo Psychico, 15451, Athens Greece
    Telephone
    Telephone
    +30 210 67 72 280-9
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.epicos.com/taxonomy/term/192420/all
    Linkedin
    Linkedin
    https://www.linkedin.com/company/epicos
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/epicoscom

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Kangpu Presents Epaldeudomide Data at 67th ASH Meeting
    Kangpu Presents Epaldeudomide Data at 67th ASH Meeting

    18 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/kangpu-to-present-latest-study-results-of-epaldeudomide-kpg-818-at-the-67th-ash-annual-meeting-302618035.html

    PR NEWSWIRE
    18 Nov 2025
    Share Share
    Kangpu Gets CDE Nod for Ph IIb SLE Trial of KPG-818
    Kangpu Gets CDE Nod for Ph IIb SLE Trial of KPG-818

    28 Apr 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/kangpu-biopharmaceuticals-received-cde-approval-for-phase-iib-clinical-trial-of-kpg-818-in-moderate-to-severe-cutaneous-manifestations-of-sle-302439526.html

    PR NEWSWIRE
    28 Apr 2025
    Share Share
    Kangpu Biopharma gets NMPA approval for KPG-818 Multiple Myeloma
    Kangpu Biopharma gets NMPA approval for KPG-818 Multiple Myeloma

    25 Feb 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/kangpu-biopharmaceuticals-received-ind-approval-from-nmpa-for-kpg-818-to-treat-relapsedrefractory-multiple-myeloma-302384336.html

    PR NEWSWIRE
    25 Feb 2025
    Share Share
    Kangpu Completed Bridging Clinical Study of KPG-818 in China
    Kangpu Completed Bridging Clinical Study of KPG-818 in China

    20 Sep 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/kangpu-completed-bridging-clinical-study-of-kpg-818-in-china-302254025.html

    PR NEWSWIRE
    20 Sep 2024
    Share Share
    Kangpu To Present KPG-818 Phase 2a SLE Data At EULAR 2024
    Kangpu To Present KPG-818 Phase 2a SLE Data At EULAR 2024

    10 Jun 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/kangpu-biopharmaceuticals-to-present-results-from-phase-2a-of-kpg-818-in-sle-at-eular-2024-302168112.html

    PR NEWSWIRE
    10 Jun 2024
    Share Share
    Kangpu Biopharmaceuticals to Present Preclinical Efficacy Data of KPG-818
    Kangpu Biopharmaceuticals to Present Preclinical Efficacy Data of KPG-818

    20 Feb 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/kangpu-biopharmaceuticals-to-present-preclinical-efficacy-data-of-kpg-818-in-crohns-disease-at-the-19th-congress-of-ecco-ind-application-for-phase-ii-in-progress-302064814.html

    PR NEWSWIRE
    20 Feb 2024
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search